Palisade Bio (PALI) Research & Development (2010 - 2026)

Palisade Bio (PALI) has 17 years of Research & Development data on file, last reported at $6.0 million in Q1 2026.

• On a quarterly basis, Research & Development rose 531.58% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $15.2 million, a 95.44% increase from a year earlier, with the FY2025 full-year figure at $10.2 million, up 12.46% from the prior year.
• Research & Development for Q1 2026 stood at $6.0 million, down from $6.2 million in the prior quarter.
• Over the last five years, Research & Development for PALI reached as high as $16.0 million in Q3 2024 and fell as low as -$11.8 million in Q4 2024.
• Historically, Research & Development has averaged $2.2 million across 5 years, with a median of $1.9 million in 2022.
• On a YoY basis, Research & Development climbed as much as 660.46% in 2024 and fell as far as 3353.87% in 2024.
• Year by year, Research & Development stood at $2.3 million in 2022, then slumped by 84.55% to $362000.0 in 2023, then slumped by 3353.87% to -$11.8 million in 2024, then surged by 152.41% to $6.2 million in 2025, then fell by 2.8% to $6.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $6.0 million in Q1 2026, $6.2 million in Q4 2025, and $1.4 million in Q3 2025.